PICC line management among patients with chronic kidney disease

Author:

Oza-Gajera Bharvi P1ORCID,Davis James A2,Farrington Crystal3,Lerma Edgar V4ORCID,Moossavi Shahriar5,Sheta Mohamed A6,Dwyer Amy7,Almehmi Ammar3ORCID

Affiliation:

1. University of Cincinnati, Cincinnati, OH, USA

2. Washington University North County Dialysis, St. Louis, MO, USA

3. University of Alabama at Birmingham, Birmingham, AL, USA

4. Section of Nephrology, University of Illinois at Chicago College of Medicine, Chicago, CA, USA

5. Wake Forest School of Medicine, Winston-Salem, NC, USA

6. Global Vascular Access Center, Houston, TX, USA

7. University of Louisville, Louisville, KY, USA

Abstract

More than 1 million peripherally inserted central catheters (PICC) are placed annually in the US and are used to provide convenient vascular access for a variety of reasons including long term antibiotic treatment, chemotherapy, parenteral nutrition, and blood draws. Although they are relatively easy to place and inexpensive, PICC line use is associated with many complications such as phlebitis/thrombophlebitis, venous thrombosis, catheter-related infection, wound infection, and central vein stenosis. These complications are far more deleterious for patients with chronic kidney disease (CKD) whose lives depend on a functioning hemodialysis access once they reach end stage kidney disease (ESKD). Despite recent guidelines to avoid PICC lines in CKD and ESKD patients, clinical use remains high. There is an ongoing urgency to educate and inform health care providers and the CKD patients themselves in preserving their venous real estate. In this article, we review AV access and PICC line background, complications associated with PICC lines in the CKD population, and recommendations for alternatives to placing a PICC line in this vulnerable patient population.

Publisher

SAGE Publications

Subject

Nephrology,Surgery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3